LV-MAX™ Lentiviral Production System

LV-MAX™ Lentiviral Production System

4.7 (621) · $ 1099.99 · In stock

Description

The Gibco LV-MAX Lentiviral Production System is the first optimized system that provides a scalable and high-yield lentiviral vector production

LV-MAX™ Lentiviral Production System

Uncovering global SUMOylation signaling networks in a site-specific manner

LV-MAX™ Lentiviral Production System

Chimeric antigen receptor‐modified macrophages trigger systemic anti‐tumour immunity - Niu - 2021 - The Journal of Pathology - Wiley Online Library

LV-MAX™ Lentiviral Production System

Full article: Ion channels as therapeutic antibody targets

LV-MAX™ Lentiviral Production System

From Ancient to Emerging Infections: The Odyssey of Viruses in the Male Genital Tract

LV-MAX™ Lentiviral Production System

Full article: Isoginkgetin, a potential CDK6 inhibitor, suppresses SLC2A1/GLUT1 enhancer activity to induce AMPK-ULK1-mediated cytotoxic autophagy in hepatocellular carcinoma

LV-MAX™ Lentiviral Production System

UCLA Crump Institute Molecular Imaging Technology Center

LV-MAX™ Lentiviral Production System

Glycolysis regulates KRAS plasma membrane localization and function through defined glycosphingolipids

LV-MAX™ Lentiviral Production System

Cells, Free Full-Text

LV-MAX™ Lentiviral Production System

Chimeric antigen receptor T‐cell therapies: Optimising the dose - Dasyam - 2020 - British Journal of Clinical Pharmacology - Wiley Online Library